Enanta Pharmaceuticals's quarterly market cap
declined
from Mar. 2024 ($369.79 Mil) to Jun. 2024 ($274.73 Mil) and
declined
from Jun. 2024 ($274.73 Mil) to Sep. 2024 ($219.57 Mil).
Enanta Pharmaceuticals's annual market cap
declined
from Sep. 2022 ($1,078.43 Mil) to Sep. 2023 ($235.23 Mil) and
declined
from Sep. 2023 ($235.23 Mil) to Sep. 2024 ($219.57 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Enanta Pharmaceuticals's Enterprise Value for Today is $-9.60 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Enanta Pharmaceuticals's Market Cap
For the Biotechnology subindustry, Enanta Pharmaceuticals's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Enanta Pharmaceuticals's Market Cap Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Enanta Pharmaceuticals's Market Cap distribution charts can be found below:
* The bar in red indicates where Enanta Pharmaceuticals's Market Cap falls into.
Enanta Pharmaceuticals Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Enanta Pharmaceuticals's Market Cap for the fiscal year that ended in Sep. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enanta Pharmaceuticals (NAS:ENTA) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Enanta Pharmaceuticals Market Cap Related Terms
Thank you for viewing the detailed overview of Enanta Pharmaceuticals's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Enanta Pharmaceuticals Inc is an American biotechnology company which uses robust, chemistry-driven approach and drug discovery capabilities to focus on the research and development of molecule drugs to cure viral infections and liver diseases. Uses virology and immunology method for curing the diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ENTA has been successfully added to your 